Tech Company Financing Transactions

Culture Biosciences Funding Round

Culture Biosciences secured a $5.5 million investment round on 2/13/2019. Investors included Section 32, Refactor Capital and Verily.

Transaction Overview

Announced On
2/13/2019
Transaction Type
Venture Equity
Amount
$5,500,000
Round
Undisclosed
Investors

Section 32 (Lead Investor) (Michael Pellini)

Refactor Capital

Verily

Proceeds Purpose
Culture will use the funding to expand its digital biomanufacturing platform and develop additional bioreactor facilities.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
269 E. Grand Ave.
San Francisco, CA 94080
USA
Phone
Undisclosed
Email Address
Overview
Culture Biosciences is a biotechnology company based in South San Francisco, CA, that's building the future of biomanufacturing. Culture's digital biomanufacturing platform enables companies to run, monitor and analyze bioreactor experiments from the cloud.
Profile
Culture Biosciences LinkedIn Company Profile
Social Media
Culture Biosciences Company Twitter Account
Company News
Culture Biosciences News
Facebook
Culture Biosciences on Facebook
YouTube
Culture Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
William Patrick
  William Patrick LinkedIn Profile  William Patrick Twitter Account  William Patrick News  William Patrick on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/13/2019: Massless venture capital transaction
Next: 2/13/2019: Wurk venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary